Navigation Links
Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
Date:7/31/2008

Conference Call and Webcast to Follow

ROCKVILLE, Md., July 31 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced it will release results for the second quarter ended June 30, 2008, on Tuesday, August 5, 2008, before the market opens. A full text copy of the release will be disseminated at that time.

Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer, will host a conference call to discuss the results and other corporate developments at 10:30 AM ET on Tuesday, August 5, 2008. Also participating on the call will be Steven A. Shallcross, Senior Vice President and CFO. To participate in the conference call, dial the appropriate number below shortly before the 10:30 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos.

The teleconference dial-in numbers are as follows:

Domestic callers 1-800-259-0251

International callers 1-617-614-3671

The conference call will be broadcast simultaneously and archived on the company's Web site, http://www.vandapharma.com . Investors should go to the Web site at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Tuesday, August 5, 2008, beginning at 12:30 PM ET and will be accessible until Thursday, September 4, 2008, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The access number is 985295
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
2. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
3. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
4. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
5. Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
6. Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights
7. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
8. Poniard Pharmaceuticals Announces Upcoming Conference Participation
9. Indevus Pharmaceuticals to Announce Third Quarter Fiscal 2008 Financial Results on August 5, 2008
10. VioQuest Pharmaceuticals, Inc Valuation Upgrade Review Issued By Scimitar Equity, LLC
11. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... IN (PRWEB) May 05, 2015 The ... the state of Indiana, led by Indiana Gov. Mike ... Day. The AMA Foundation will host a Family Fest ... celebration. All proceeds will benefit the Wounded Warrior Project. ... the Academy of Model Aeronautics—the country’s foremost organization for ...
(Date:5/5/2015)...  A group of biotechnology executives and medical doctors ... a non-profit organization dedicated to providing education, research and ... of consciousness.  ... Coma is ... voluntary actions can be initiated by the patient, and ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... addition of the "Clinical Laboratory, Molecular Diagnostics ... 2015 to 2019 - Europe Version" report ... especially in the area of molecular diagnostics and ... and evolving world market that is moving out ...
(Date:5/5/2015)... 05, 2015 Exotic Automation ... announces the launch of http://www.cng.exoticautomation.com , an ... a convenient way to purchase genuine OEM replacement ... , The new website provides owners of ... direct access to high performance products for their ...
Breaking Biology Technology:State of Indiana proclaims August 15 as Model Aviation Day 2Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 2Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 3Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 4Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 5European Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2Exotic Automation & Supply Launches Ecommerce Website 2
... 3 Metabolex, Inc., a,biopharmaceutical company focused ... medicines for the treatment of metabolic diseases,announced ... MBX-8025) have been,recognized in Windhover,s "Top 10 ... respective categories. MBX-2982, a potential,first-in-class treatment for ...
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmaceutical ... therapeutics for,the treatment of solid and hematologic cancers, today ... upcoming conferences:, Rodman & Renshaw 10th Annual Healthcare ... Wednesday, November 12, 2008, 2:00 p.m. EST, ...
... Catalyst,Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) a ... prescription,drugs for the treatment of drug addiction and ... Chief Executive,Officer, will be presenting an overview of ... Global Investment Conference on Tuesday, November 11,2008 at ...
Cached Biology Technology:Two Metabolex Projects Recognized in Windhover's Top 10 Lists for Partnering Opportunities 2Two Metabolex Projects Recognized in Windhover's Top 10 Lists for Partnering Opportunities 3Sunesis to Present at Upcoming Conferences 2Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference 2
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
(Date:3/20/2015)... , Mar. 20, 2015 Research and ... the addition of the "India Sensors Market ... offering. The sensor market is projected ... 2020 Consumer electronics, automotive, industrial and ... sensors in the country. In addition, adoption of ...
(Date:3/20/2015)... OXFORD, Conn. , March 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... Wocket® smart wallet is one of the products featured ... today, March 20th at 11:00 PM EST on the ... travels to Las Vegas , site ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... defences and causes disease,by sneakily disabling the plant,s intruder ... December) in Current Biology . ... bacterial speck disease,in tomato plants. This bacterial invasion causes ... extensive and costly damage to,tomato crops, and researchers believe ...
... men want younger women, often touting their intelligence and ... at Gothenburg University and Oxford University that studied 400 ... choose partners. Research in the theory of evolution ... and women choose their partners. Among the more ...
... it,s easy to forget that a dam and pond stood ... Research Station in southwestern Wisconsin. All traces of the structure ... now carpet the floor of the former basin. Nevertheless, ... soils of the basin, UW-Madison researchers are now unearthing them. ...
Cached Biology News:Red alert! How disease disables tomato plant's 'intruder alarm' 2Myth about 'dirty old men' supported by science 2Researchers examine role of soil patterns in dam restoration 2Researchers examine role of soil patterns in dam restoration 3